DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

March 16, 2009 updated by: AstraZeneca

A Comparison of Symbicort Single Inhaler Therapy (Symbicort Turbuhaler 160/4.5 µg, 1 Inhalation b.i.d. Plus as Needed) and Conventional Best Practice for the Treatment of Persistent Asthma in Adults - a 26-Week, Randomised, Open-Label, Parallel-Group, Multicentre Study

The purpose of this study is to determine whether Symbicort dosed according to the Symbicort Maintenance and Reliever Therapy (SMART) concept is superior to standard asthma treatment according to the local German treatment guidelines.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
1600

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
      • Amberg, Germany
        • Research Site
      • Aschaffenburg, Germany
        • Research Site
      • Auerbach, Germany
        • Research Site
      • Augsburg, Germany
        • Research Site
      • Backnang, Germany
        • Research Site
      • Bad Arolsen, Germany
        • Research Site
      • Bad Doberan, Germany
        • Research Site
      • Bad Lippspringe, Germany
        • Research Site
      • Bad Neuenahr, Germany
        • Research Site
      • Bad Reichenhall, Germany
        • Research Site
      • Bad Sessendorf, Germany
        • Research Site
      • Bayreuth, Germany
        • Research Site
      • Bensheim, Germany
        • Research Site
      • Bergisch Gladbach, Germany
        • Research Site
      • Berlin, Germany
        • Research Site
      • Bitte Eintragen, Germany
        • Research Site
      • Bochum, Germany
        • Research Site
      • Bonn, Germany
        • Research Site
      • Borna, Germany
        • Research Site
      • Brake, Germany
        • Research Site
      • Burg, Germany
        • Research Site
      • Burgwedel, Germany
        • Research Site
      • Castrop-Rauxel, Germany
        • Research Site
      • Chemnitz, Germany
        • Research Site
      • Coswig, Germany
        • Research Site
      • Cottbus, Germany
        • Research Site
      • Damme, Germany
        • Research Site
      • Darmstadt, Germany
        • Research Site
      • Deggendorf, Germany
        • Research Site
      • Dillingen, Germany
        • Research Site
      • Dinslaken, Germany
        • Research Site
      • Dortmund, Germany
        • Research Site
      • Dresden, Germany
        • Research Site
      • Dülmen, Germany
        • Research Site
      • Düsseldorf, Germany
        • Research Site
      • Eisenach, Germany
        • Research Site
      • Eisenhüttenstadt, Germany
        • Research Site
      • Emden, Germany
        • Research Site
      • Erfurt, Germany
        • Research Site
      • Erkelenz, Germany
        • Research Site
      • Eschwege, Germany
        • Research Site
      • Flensburg, Germany
        • Research Site
      • Forchheim, Germany
        • Research Site
      • Frankenthal, Germany
        • Research Site
      • Frankfurt, Germany
        • Research Site
      • Freiberg, Germany
        • Research Site
      • Freiburg, Germany
        • Research Site
      • Freising, Germany
        • Research Site
      • Fulda, Germany
        • Research Site
      • Fürstenwalde, Germany
        • Research Site
      • Fürth, Germany
        • Research Site
      • Gelsenkirchen, Germany
        • Research Site
      • Gießen, Germany
        • Research Site
      • Gotha, Germany
        • Research Site
      • Göppingen, Germany
        • Research Site
      • Günzburg, Germany
        • Research Site
      • Gütersloh, Germany
        • Research Site
      • Hagen, Germany
        • Research Site
      • Halle, Germany
        • Research Site
      • Hamburg, Germany
        • Research Site
      • Hamm, Germany
        • Research Site
      • Hannover, Germany
        • Research Site
      • Harpstedt, Germany
        • Research Site
      • Hartha, Germany
        • Research Site
      • Heidelberg, Germany
        • Research Site
      • Heilbronn, Germany
        • Research Site
      • Homburg-Saar, Germany
        • Research Site
      • Hoyerswerda, Germany
        • Research Site
      • Iserloh, Germany
        • Research Site
      • Kamen, Germany
        • Research Site
      • Kamenz, Germany
        • Research Site
      • Kamp-Lintfort, Germany
        • Research Site
      • Karlsruhe, Germany
        • Research Site
      • Kassel, Germany
        • Research Site
      • Kaufbeuren, Germany
        • Research Site
      • Kempten, Germany
        • Research Site
      • Kiel, Germany
        • Research Site
      • Kitzingen, Germany
        • Research Site
      • Koblenz, Germany
        • Research Site
      • Krefeld, Germany
        • Research Site
      • Kronach, Germany
        • Research Site
      • Köln, Germany
        • Research Site
      • Landsberg, Germany
        • Research Site
      • Leipzig, Germany
        • Research Site
      • Leonberg, Germany
        • Research Site
      • Leverkusen, Germany
        • Research Site
      • Ludwigsburg, Germany
        • Research Site
      • Lörrach, Germany
        • Research Site
      • Lübeck, Germany
        • Research Site
      • Lüneburg, Germany
        • Research Site
      • Magdeburg, Germany
        • Research Site
      • Mainaschaff, Germany
        • Research Site
      • Mainz, Germany
        • Research Site
      • Marburg, Germany
        • Research Site
      • Markkleeberg, Germany
        • Research Site
      • Memmingen, Germany
        • Research Site
      • Moers, Germany
        • Research Site
      • Mönchengladbach, Germany
        • Research Site
      • Mühlhausen, Germany
        • Research Site
      • München, Germany
        • Research Site
      • Neubrandenburg, Germany
        • Research Site
      • Neuss, Germany
        • Research Site
      • Neuwied, Germany
        • Research Site
      • Niesky, Germany
        • Research Site
      • Nordhausen, Germany
        • Research Site
      • Oberhausen, Germany
        • Research Site
      • Oranienburg, Germany
        • Research Site
      • Oschersleben, Germany
        • Research Site
      • Paderborn, Germany
        • Research Site
      • Passau, Germany
        • Research Site
      • Peine, Germany
        • Research Site
      • Pforzheim, Germany
        • Research Site
      • Pinneberg, Germany
        • Research Site
      • Potsdam, Germany
        • Research Site
      • Ratingen, Germany
        • Research Site
      • Recklinghausen, Germany
        • Research Site
      • Regensburg, Germany
        • Research Site
      • Reutlingen, Germany
        • Research Site
      • Rheine, Germany
        • Research Site
      • Rodenbach, Germany
        • Research Site
      • Rostock, Germany
        • Research Site
      • Rottweil, Germany
        • Research Site
      • Rudolstadt, Germany
        • Research Site
      • Saalfeld, Germany
        • Research Site
      • Saarbrücken, Germany
        • Research Site
      • Saarlouis, Germany
        • Research Site
      • Salzgitter, Germany
        • Research Site
      • Sangerhausen, Germany
        • Research Site
      • Schleswig, Germany
        • Research Site
      • Schwabach, Germany
        • Research Site
      • Schwerin, Germany
        • Research Site
      • Schwäbisch Gmünd, Germany
        • Research Site
      • Siegen, Germany
        • Research Site
      • Simmern, Germany
        • Research Site
      • Sindelfingen, Germany
        • Research Site
      • Singen, Germany
        • Research Site
      • Solingen, Germany
        • Research Site
      • Stade, Germany
        • Research Site
      • Stadthagen, Germany
        • Research Site
      • Steinhagen, Germany
        • Research Site
      • Stuttgart, Germany
        • Research Site
      • Trier, Germany
        • Research Site
      • Ulm, Germany
        • Research Site
      • Uttenreuth, Germany
        • Research Site
      • Wardenburg, Germany
        • Research Site
      • Wedel, Germany
        • Research Site
      • Weinheim, Germany
        • Research Site
      • Weyhe, Germany
        • Research Site
      • Witten, Germany
        • Research Site
      • Worpswede, Germany
        • Research Site
      • Würzburg, Germany
        • Research Site
      • Zerbst, Germany
        • Research Site
      • Zwickau, Germany
        • Research Site
    • Baden-Württemberg
      • Stuttgart, Baden-Württemberg, Germany
        • Research Site
    • Bayern
      • München, Bayern, Germany
        • Research Site
    • Brandenburg
      • Cottbus, Brandenburg, Germany
        • Research Site
    • Hessen
      • Frankfurt, Hessen, Germany
        • Research Site
    • Mecklenburg-Vorpommern
      • Rostock, Mecklenburg-Vorpommern, Germany
        • Research Site
    • Niedersachsen
      • Hannover, Niedersachsen, Germany
        • Research Site
    • Nordrhein-Westfalen
      • Düsseldorf, Nordrhein-Westfalen, Germany
        • Research Site
      • Münster, Nordrhein-Westfalen, Germany
        • Research Site
    • Rheinland-Pfalz
      • Mainz, Rheinland-Pfalz, Germany
        • Research Site
    • Saarland
      • Saarbrücken, Saarland, Germany
        • Research Site
    • Sachsen
      • Dresden, Sachsen, Germany
        • Research Site
    • Sachsen-Anhalt
      • Halle, Sachsen-Anhalt, Germany
        • Research Site
    • Schleswig-Holstein
      • Bad Segeberg, Schleswig-Holstein, Germany
        • Research Site
    • Thüringen
      • Jena-Maua, Thüringen, Germany
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with asthma, either well-controlled on a regular therapy with a combination of long-acting beta-agonists and inhaled corticosteroids or symptomatic on therapy with inhaled corticosteroids alone.

Exclusion Criteria:

  • Any other significant lung disease other than asthma
  • Any disease that might put patients at risk if they participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Time to first severe asthma exacerbation

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Number of severe asthma exacerbations
Mean use of as-needed medication
Change in forced expiratory volume in 1 second (FEV1) from the end of run-in to the end of the study period
Prescribed asthma medication during the treatment period
Asthma Control Questionnaire (ACQ)
Patient's satisfaction with the treatment question
Health care contacts
Asthma medication
Time lost from paid and unpaid work
Serious adverse events (SAEs)
Discontinuations due to adverse events (AEs)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
AstraZeneca

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Heinrich Worth, MD, Klinikum Fürth

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
December 1, 2004

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 1, 2006

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 14, 2005

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 14, 2005

First Posted (Estimate)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
November 15, 2005

Study Record Updates

Last Update Posted (Estimate)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 17, 2009

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 16, 2009

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2009

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • D5890L00011
  • DESOLO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings